# Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study

> **NCT00628498** · PHASE3 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 1206 (actual)

## Conditions studied

- Hepatic Veno-Occlusive Disease

## Interventions

- **DRUG:** Defibrotide
- **DRUG:** Defibrotide

## Key facts

- **NCT ID:** NCT00628498
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2016-07
- **Final completion:** 2016-09
- **Target enrollment:** 1206 (ACTUAL)
- **Last updated:** 2017-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00628498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00628498, "Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00628498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*